KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Operations: 2020-2025

Historic Cash from Operations for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$31.6 million.

  • Ginkgo Bioworks Holdings' Cash from Operations rose 69.46% to -$31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.8 million, marking a year-over-year increase of 50.50%. This contributed to the annual value of -$319.6 million for FY2024, which is 8.15% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Cash from Operations stood at -$31.6 million, which was up 21.48% from -$40.3 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Cash from Operations' 5-year high stood at -$5.2 million during Q3 2021, with a 5-year trough of -$165.5 million in Q4 2021.
  • In the last 3 years, Ginkgo Bioworks Holdings' Cash from Operations had a median value of -$73.5 million in 2023 and averaged -$67.1 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Cash from Operations plummeted by 441.76% in 2022, and later skyrocketed by 69.46% in 2025.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Cash from Operations stood at -$165.5 million in 2021, then spiked by 36.85% to -$104.5 million in 2022, then spiked by 44.68% to -$57.8 million in 2023, then grew by 26.62% to -$42.4 million in 2024, then surged by 69.46% to -$31.6 million in 2025.
  • Its last three reported values are -$31.6 million in Q3 2025, -$40.3 million for Q2 2025, and -$51.5 million during Q1 2025.